Empr - empr.com - Latest articles from MPR
General Information:
Latest News:
NAMENDA XR 27 Aug 2013 | 09:00 am
Monograph added.
Valchlor Topical Gel Approved for Early Stage Cutaneous T-cell Lymphoma 26 Aug 2013 | 09:09 pm
Valchlor topical gel has been granted marketing approval for the treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma (CTCL) in patients who have received prior skin-directed ...
Mirvaso Topical Gel Approved for Facial Erythema of Rosacea 26 Aug 2013 | 09:03 pm
The FDA has approved Galderma's Mirvaso (brimonidine) topical gel for the topical treatment of the facial erythema associated with rosacea in adults 18 years or older.
JAKAFI 26 Aug 2013 | 09:00 am
Expanded dosing for patients with low platelet counts.
Pennsaid 2% NDA Under Review for Osteoarthritis of the Knee 23 Aug 2013 | 09:28 pm
DECK: The FDA has accepted for filing the New Drug Application (NDA) for Pennsaid (diclofenac sodium topical solution; Mallinckrodt) 2% w/w in the treatment for pain associated with osteoarthritis of ...
Ortiga Supplement Contains Hidden NSAID 23 Aug 2013 | 07:20 pm
The FDA is advising against the purchase and use of Ortiga after it was found to contain diclofenac, a prescription NSAID.
FABIOR 23 Aug 2013 | 09:00 am
Monograph added.
Gilotrif Available Soon for NSCLC 22 Aug 2013 | 10:51 pm
Gilotrif (afatinib) tablets will be commercially available in the U.S. beginning the week of September 2.
Dr. Reddy's Launches Generic Depakote ER 22 Aug 2013 | 09:49 pm
Dr. Reddy's Laboratories announced the launch of Divalproex Sodium Extended-Release Tablets, the generic version of AbbVie's Depakote ER.
Astagraf XL Capsules Now Available 22 Aug 2013 | 07:20 pm
Astellas announced the availability of Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant.
